代谢应激诱导的人胰岛β细胞死亡是由细胞内腺苷水平升高介导的。
Metabolic stress-induced human beta-cell death is mediated by increased intracellular levels of adenosine.
机构信息
Science for Life Laboratory, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Division of Anatomy, Department of Preclinical Sciences, Faculty of Medicine, Thammasat University, Khlong Luang, Pathumthani, Thailand.
出版信息
Front Endocrinol (Lausanne). 2023 Jan 25;14:1060675. doi: 10.3389/fendo.2023.1060675. eCollection 2023.
INTRODUCTION
High intracellular concentrations of adenosine and 2'-deoxyadenosine have been suggested to be an important mediator of cell death. The aim of the present study was to characterize adenosine-induced death in insulin-producing beta-cells, at control and high glucose + palmitate-induced stress conditions.
METHODS
Human insulin-producing EndoC-betaH1 cells were treated with adenosine, 2'-deoxyadenosine, inosine and high glucose + sodium palmitate, and death rates using flow cytometry were studied.
RESULTS
We observed that adenosine and the non-receptor-activating analogue 2-deoxyadenosine, but not the adenosine deamination product inosine, promoted beta-cell apoptosis at concentrations exceeding maximal adenosine-receptor stimulating concentrations. Both adenosine and inosine were efficiently taken up by EndoC-betaH1 cells, and inosine counteracted the cell death promoting effect of adenosine by competing with adenosine for uptake. Both adenosine and 2'-deoxyadenosine promptly reduced insulin-stimulated production of plasma membrane PI(3,4,5)P, an effect that was reversed upon wash out of adenosine. In line with this, adenosine, but not inosine, rapidly diminished Akt phosphorylation. Both pharmacological Bax inhibition and Akt activation blocked adenosine-induced beta-cell apoptosis, indicating that adenosine/2'-deoxyadenosine inhibits the PI3K/Akt/BAD anti-apoptotic pathway. High glucose + palmitate-induced cell death was paralleled by increased intracellular adenosine and inosine levels. Overexpression of adenosine deaminase-1 (ADA1) in EndoC-betaH1 cells, which increased Akt phosphorylation, prevented both adenosine-induced apoptosis and high glucose + palmitate-induced necrosis. ADA2 overexpression not only failed to protect against adenosine and high glucose + palmitate-activated cell death, but instead potentiated the apoptosis-stimulating effect of adenosine. In line with this, ADA1 overexpression increased inosine production from adenosine-exposed cells, whereas ADA2 did not. Knockdown of ADA1 resulted in increased cell death rates in response to both adenosine and high glucose + palmitate. Inhibition of miR-30e-3p binding to the ADA1 mRNA 3'-UTR promoted the opposite effects on cell death rates and reduced intracellular adenosine contents.
DISCUSSION
It is concluded that intracellular adenosine/2'-deoxyadenosine regulates negatively the PI3K pathway and is therefore an important mediator of beta-cell apoptosis. Adenosine levels are controlled, at least in part, by ADA1, and strategies to upregulate ADA1 activity, during conditions of metabolic stress, could be useful in attempts to preserve beta-cell mass in diabetes.
简介
高细胞内浓度的腺苷和 2'-脱氧腺苷被认为是细胞死亡的一个重要介质。本研究的目的是在正常葡萄糖和高葡萄糖+棕榈酸诱导应激条件下,研究胰岛素分泌β细胞中腺苷诱导的死亡。
方法
用腺苷、2'-脱氧腺苷、肌苷和高葡萄糖+棕榈酸钠处理人胰岛素分泌细胞 EndoC-betaH1,并通过流式细胞术研究死亡率。
结果
我们观察到,腺苷和非受体激活类似物 2'-脱氧腺苷,而不是腺苷脱氨酶产物肌苷,在浓度超过最大腺苷受体刺激浓度时促进β细胞凋亡。腺苷和肌苷都能被 EndoC-betaH1 细胞有效摄取,肌苷通过与腺苷竞争摄取来拮抗腺苷促进细胞死亡的作用。腺苷和 2'-脱氧腺苷都迅速降低胰岛素刺激的质膜 PI(3,4,5)P 的产生,这种作用在洗脱腺苷后逆转。与此一致的是,腺苷而不是肌苷迅速降低 Akt 磷酸化。两种药理学 Bax 抑制和 Akt 激活都阻断了腺苷诱导的β细胞凋亡,表明腺苷/2'-脱氧腺苷抑制了 PI3K/Akt/BAD 抗凋亡途径。高葡萄糖+棕榈酸诱导的细胞死亡伴随着细胞内腺苷和肌苷水平的增加。EndoC-betaH1 细胞中腺苷脱氨酶-1(ADA1)的过表达增加了 Akt 磷酸化,防止了腺苷诱导的凋亡和高葡萄糖+棕榈酸诱导的坏死。ADA2 的过表达不仅不能防止腺苷和高葡萄糖+棕榈酸激活的细胞死亡,反而增强了腺苷的促凋亡作用。与此一致的是,ADA1 过表达增加了暴露于腺苷的细胞中肌苷的产生,而 ADA2 则没有。ADA1 的敲低导致对腺苷和高葡萄糖+棕榈酸盐的细胞死亡率增加。miR-30e-3p 与 ADA1 mRNA 3'-UTR 结合的抑制促进了对细胞死亡率和细胞内腺苷含量的相反影响。
讨论
结论是,细胞内腺苷/2'-脱氧腺苷负调节 PI3K 途径,因此是β细胞凋亡的一个重要介质。腺苷水平至少部分受 ADA1 控制,在代谢应激条件下上调 ADA1 活性的策略可能有助于在糖尿病中保留β细胞质量。
相似文献
Front Endocrinol (Lausanne). 2023
引用本文的文献
Front Cell Infect Microbiol. 2024-7-17
本文引用的文献
Nucleosides Nucleotides Nucleic Acids. 2022
Biol Pharm Bull. 2020